Last edition
Home › News › Quality / GMP
Zydus Lifesciences Limit has received final approval from the United States Food and Drug Administration (US FDA) to manufacture and market Tavaborole Topical Solution, 5 per cent.
Tavaborole topical solution is indicated to treat fungal toenail infections (infections that may cause nail discolouration, splitting, or pain). The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad.
Zydus receives US FDA approval for Tavaborole Topical Solution, 5%
Zydus Lifesciences Limit has received final approval from the United States Food and Drug Administration (US FDA) to manufacture and market Tavaborole Topical Solution, 5 per cent.
Tavaborole topical solution is indicated to treat fungal toenail infections (infections that may cause nail discolouration, splitting, or pain). The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad.
More news about: quality / gmp | Published by Sudeep Soparkar | April - 13 - 2023 | 444
Last news about this category
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members